美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Virtus LifeSci Biotech Products ETF

100.71

-2.9227-2.82%

盘后：100.71-0.00220.00%16:10 EDT

成交量：1.23万

成交额：125.26万

市值：1.26亿

市盈率：- -

高：103.68

开：103.68

低：100.71

收：103.63

52周最高：110.05

52周最低：70.30

股本：125.00万

流通股本：125.00万

量比：1.19

换手率：0.99%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

特朗普：美国利率应降至1%或以下

特朗普社媒动态

特朗普：美国利率应为1%或更低

特朗普社媒动态

白宫称美联储加息举措“相当令人遗憾”

五张图表揭示市场对美联储决议的即时反应

阿斯利康股价盘后跌超2%，因其三期临床试验结果令人失望。

118款生物药专利悬崖将至，中国药企业迎战MNC最大专利悬崖

复宏汉霖朱俊：未来所有制药企业都是AI制药企业，不存在不依赖AI的生物制药企业

特朗普：8月就业数据超预期，要求美联储降息

特朗普社媒动态

康宁杰瑞生物制药回购56,000股耗资492,430港元

美股异动丨诺华制药涨超7%，多发性硬化症口服药后期临床试验结果积极

药闻 | 英硅智能上市后首份半年报扭亏创新药研发加速拥抱AI

武汉友芝友生物制药股份有限公司在香港暂停交易。

新股消息 | 贝达药业(300558.SZ)再度递表港交所 “四驾马车”协同打造全产业链生物制药

联环药业上半年扭亏为盈集采续采与创新药研发协同推进

海正药业与星际开发达成战略合作布局太空生物制药

博济医药2026年半年报：创新药研发需求复苏，在手订单充足，经营现金流明显下滑

阿巴斯生物制药宣布拟通过改良式“荷兰拍卖”要约收购，回购最高价值2.3亿美元的公司普通股。

骏利亨德森投资：专利到期倒逼药企扩张生物科技并购、IPO市场同步复苏

智通财经网

杭萧钢构等投资成立生物制药公司

中国银河证券：实验动物为创新药研发刚需小鼠+猴双主线高景气

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BBP/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":100.7072,"timestamp":1791921600000,"preClose":103.6299,"halted":0,"volume":12317,"hourTrading":{"tag":"盘后","latestPrice":100.705,"preClose":100.7072,"latestTime":"16:10 EDT","volume":6,"amount":604.2432,"timestamp":1791922204895,"change":-0.0022,"changeRate":-0.000022,"amplitude":0},"delay":0,"changeRate":-0.02820325022025502,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"已收盘","change":-2.9227,"latestTime":"10-13 16:00:00 EDT","open":103.68,"high":103.68,"low":100.705,"amount":1252625,"amplitude":0.028708,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.6299,"sharesOutstanding":600004,"nav":103.535,"aum":129419787.56,"bidAskSpread":0.002365,"preHourTrading":{"tag":"盘前","latestPrice":103.6299,"preClose":103.6299,"latestTime":"07:01 EDT","volume":1,"amount":103.6299,"timestamp":1791889277032,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":100.705,"preClose":100.7072,"latestTime":"16:10 EDT","volume":6,"amount":604.2432,"timestamp":1791922204895,"change":-0.0022,"changeRate":-0.000022,"amplitude":0},"volumeRatio":1.187181,"impliedVol":0.2467,"impliedVolPercentile":0.6972},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.187181,"shares":1250004,"dividePrice":0,"high":103.68,"amplitude":0.028708,"preClose":103.6299,"low":100.705,"week52Low":70.303,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":100.7072,"eps":0,"divideRate":0,"volume":12317,"delay":0,"ttmEps":0,"open":103.68,"prevYearClose":79.9149,"prevWeekClose":104.7564,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":100.9666,"twentyDayClose":101.1392,"sixtyDayClose":96.3276},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1114356236","title":"特朗普：美国利率应降至1%或以下","url":"https://stock-news.laohu8.com/highlight/detail?id=1114356236","media":"特朗普社媒动态","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114356236?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 04:38","pubTimestamp":1789591115,"startTime":"0","endTime":"0","summary":"美国总统特朗普9月16日在社交平台发文称，美国利率应降至1%或更低，因为美国拥有全球最佳信用。他声称美国投资蓬勃发展，若停止与所有贸易逆差国家交易，每年可赚取1.5万亿美元。\n特朗普在帖子中写道：“赤字这个词不过是‘亏损’的花哨说法。”他认为美国正在“承受”几乎每个国家的负担，并呼吁“迅速降低美国利率”。特朗普强调，美国应当利用自身信用优势来促进经济繁荣。\n截至发稿，美联储尚未对此公开回应。特朗普的言论再次引发市场对利率政策走向的讨论，目前联邦基金利率目标区间为5.25%至5.50%。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPYU","VPX","07766","LRCY","SH","QQQX","TSL","DDM",".SPX","TSLZ","LQDH","TSLI","07568","TSDD","QLD","IVV","SPY","DIA","TSLG","ELOL","HEEM","09834","CRSH","DXD","09366","IBCB","NJUL","TSLW","NAPR","OVS","TESC","DFUV","BK4588","FXL","THIR","SSO","VOO","TSLL","QQQ","MMAX","SCEP","IJK","SQQQ","TQQQ","TQQY","SPXL","GPIQ","09086","TSYY","RJZ","TSLY","TSLO","CGDV","TLA","SDS","HIBL","DMAX","03086","ANEW","07266","KOMP","NJAN","SMAX","02834","09766","TSLS","TSLT","AVSD","FXR","SPUU","SHUS","07366","BK4585","NOCT","TSLP","AMHI","QMAR","SPDN","07522","YSPY","CAOS",".IXIC","QID","CLIX","SPYH","03455","HYXF","JA","UPRO","PSQ","PEVC","07261","SPXU","TEST","VAW","SPYM","03034","TSII","SPYQ","QQQM","TSLR","UDOW","SPXS","QDEC","RVRB",".DJI","BBP","UCC","DOG","SDOW","TSLQ","LQDB","TESL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114155151","title":"特朗普：美国利率应为1%或更低","url":"https://stock-news.laohu8.com/highlight/detail?id=1114155151","media":"特朗普社媒动态","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114155151?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 04:38","pubTimestamp":1789591115,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03086","OVS","IBCB","IJK","SMAX","07766","PEVC",".SPX","RVRB","SPYQ","MMAX","TSL","ELOL","SSO","VPX","ANEW","TSLT","03455","DXD","QID","07366","TESC","NJUL","TSLL","09766","07261","SQQQ","TSLZ","AMHI","TSII","SPDN","TSLW","TSLP","PSQ","SPXS","09366","UDOW","UPRO","QQQX","09834","03034","HYXF","LQDB","07266","DFUV","SPYU",".IXIC","FXR","SPY","YSPY","TSLR","QLD","DMAX","SPYM","QQQM","KOMP","NOCT","TSDD","DIA","TSLI","SPXL","DDM","TESL","NJAN",".DJI","DOG","THIR","NAPR","TQQQ","LQDH","SDS","BK4585","SH","SHUS","SPUU","CLIX","TLA","HIBL","TQQY","SDOW","HEEM","02834","TEST","TSYY","QMAR","TSLO","07522","CRSH","QDEC","SPXU","AVSD","QQQ","CAOS","IVV","RJZ","VAW","LRCY","07568","BK4588","GPIQ","TSLS","CGDV","FXL","SPYH","BBP","TSLQ","TSLY","SCEP","TSLG","VOO","09086","UCC","JA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163308609","title":"白宫称美联储加息举措“相当令人遗憾”","url":"https://stock-news.laohu8.com/highlight/detail?id=1163308609","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163308609?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 03:51","pubTimestamp":1789588269,"startTime":"0","endTime":"0","summary":"白宫发言人库什·德赛表示，美联储决定上调利率一事“相当令人遗憾”。德赛在福克斯新闻的一次访谈中指出：“我认为总统在利率走向上的立场已表达得极为明确。而今天，美联储选择加息，从政府的视角来看，这一决定实在缺乏足够有说服力的经济依据来支撑。”他进一步补充道：“这已不是拜登执政的时代了。总统和共和党人并未像民主党与乔·拜登那样，斥资数万亿美元用于新冠疫情刺激计划。我们并不存在那种需要通过抬升利率来遏制失控的总需求。”","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOL","LRCY","IJK","TSII","FXL","ANEW","TSLW","TSLP","07366","AVSD","BK4585","CAOS","TSDD","FXR","VAW","PEVC","07766","TLA","TSLO","RJZ","TESL","TSYY","BBP","KOMP","BK4588","09766","TSLL","TSLT","TSLQ","TSL","UCC","DFUV","TSLZ","CLIX","TSLI","TSLY","09366","TESC","TSLR","TEST","CGDV","CRSH","TSLG","TSLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182814613","title":"五张图表揭示市场对美联储决议的即时反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1182814613","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182814613?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 02:37","pubTimestamp":1789583865,"startTime":"0","endTime":"0","summary":"美联储自2023年以来首次宣布加息，这一重磅决策立刻在金融市场激起层层涟漪。投资者们屏息凝神，紧盯着各类资产价格的风向变化，试图捕捉每一个微妙的信号。从股市到债市，从美元汇率到大宗商品，无不呈现出耐人寻味的波动轨迹。整体来看，这五张图表勾勒出一幅市场在政策转向之际既紧张又充满算计的生动图景，每一根K线、每一个波动点都在诉说着投资者对未来利率路径的重新定价。","market":"hk","thumbnail":"https://static.tigerbbs.com/1c0b4eef7036bef961440319a6488bce","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1c0b4eef7036bef961440319a6488bce"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYGD","ARKD","TIP","07766","GBIL","LRCY","DVUT","ZAPR","QQQX","UDN","ZTmain","HYIN","TSL","MDPL","BCFN","SHY","BGH","TBT","BK4593","BBIB","EQIN","MYCN","FAZ","TSLZ","GOVT","TSLI","JADB","UBmain","07568","AZYY","NGHT","BAMA","QLD","TSDD","US5Y.BOND","KBWB","TSLG","GDMA","ELOL","LIAJ","QIS","09834","APOC","SKRE","VCSH","AMZU","CRSH","BINT","09366","NJUL","OCTM","FT","IALT","TSLW","ZBmain","NAPR","TESC","AMZO","SPBW","HF","ATTR","WAMA","TLTI","BAMO","VOOV","OGSP","DFUV","BK4588","JOYT","FXL","PAYH","UUP","QLDY","SGOV","KBE","KOOL","XBFR","DADS","FLSP","KRX","TLH","US12M.BOND","RULE","XLF","TSLL","USHY","QQQ","AMZG","VTV","US2Y.BOND","TMF","IJK","JULD","KHPI","OOQB","AGG","PEMX","HYGU","RAUS","LVLN","RGLO","SQQQ","QUSA","TQQQ","TQQY","SPBX","RAAA","VCIT","EMPB","GPIQ","TLTW","US3Y.BOND","FDLO","09086","AMZW","MUNX","PBDC","TSYY","OOSP","DBMF","SOVF","BOXX","MUB","TSYW","VGIT","JPO","UBT","RJZ","BWX","TSLY","HIDV","TLTX","MINT","IEF","JPMO","AMZD","EBND","BKIV","TSLO","MYCI","CGDV","TLA","VFH","BWZ","SCLZ","BUFH","IGOV","TLT","RSBA","DBND","03086","ANEW","GXDW","AMAA","07266","FITZ","GOLY","KOMP","TBIL","NJAN","US30Y.BOND","CDIG","ZSEP","02834","09766","ISSXF","TSLS","TSLT","AVSD","EIM","TNmain","EDV","FXR","DPST","07366","SSEUF","BK4585","HFEQ","TFJL","ABUF","NOCT","TSLP","QMAR","IAT","PTLC","SCHO","NSCI","KRE","US10Y.BOND","WLDR","07522","PBQQ","LQD","AMZZ","BND","XBIL","US6M.BOND","PRIV","CAOS","BK4581","SIXH","QID","CLIX","SDHY","XLRI","FARX","SGRT","AMZP","03455","BOND","SHV","LQDD","FLDZ","TBJL","BK4561","VGSH","HYG","PSQ","PEVC","07261","CPNM","BK4535","BBLB","TEST","PLGI","VAW","OCTU","03034","RORO","BK4504","TSII","ZFmain","BSV","QQQM","TSLR","ISHG","VEXC","MFMO","EQRR","ITDH","NQLT","US7Y.BOND","AMZY","LQ","LALT","AAUB","NELS","QDEC","BIL","SLTY","BBP","UCC","ZROZ","HAWG","LQDU","BK4550","FLGV","JPST","NEMD","EOPS","TYO","IEI","BBSB","TSLQ","VGLT","CIVG","TESL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股价盘后跌超2%，因其三期临床试验结果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_cn&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IYH","HELX","IE00B5TLWC47.USD","CANC","XBIX","LU2272731600.USD","PBE","LU2272731782.SGD","RXL","LU2322448791.USD","AZNH","LU2322448957.HKD","RSPH","WDNA","PSCH","SBIO","IBRN","BIOY","IEIH","LU1992135399.USD","IDNA","IBB","FTXH","BBP","PPH","BIB","BK4585","BBH","LU1992135472.HKD","MEDI","PBPH","BK4588","GNOM","LU2473716301.USD","MRNY","TMED","BME","FBT","LU2272731865.HKD","LFSC","SYNB","XPH","IEHS","PJP","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666563124","title":"118款生物药专利悬崖将至，中国药企业迎战MNC最大专利悬崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666563124?lang=zh_cn&edition=fundamental","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出，未来几年全球MNC将迎来史上最大专利悬崖，有118种生物制剂将会失去相应的专利保护，涉及2340亿美元市场。然而，目前这118款即将到期分子中，只有极少数在火热开发，大量缺口有待生物类似药填补。目前来说，创新药出海还没办法完成这个闭环，但生物类似药作为先头部队做出海试验，企业风险和获益会更高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["159839","GSKH","PPH","MEDI","IHE","RSPH","IYH","FXH","JDOC","BME","PJP","TMED","APXH","FHLC","TRUH","PBPH","BBP","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665936888","title":"复宏汉霖朱俊：未来所有制药企业都是AI制药企业，不存在不依赖AI的生物制药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2665936888","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665936888?lang=zh_cn&edition=fundamental","pubTime":"2026-09-05 14:04","pubTimestamp":1788588240,"startTime":"0","endTime":"0","summary":"朱俊坦言，尽管近年来国家批准的创新药数量已领先全球，但临床疗效的提升依然艰难。他强调，如果AI不能进一步赋能，生物医药产业将继续处于原始状态。未来，所有的制药企业都必须是AI制药企业，不存在不依赖AI的生物制药企业。朱俊总认为，在全球变局下，只要企业能够用好AI、抓住精准人群并解决真实的临床痛点，即使十个机会中只能抓住一个，也足以支撑企业的长远发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccs3668085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HK0000320223.HKD","CHAT","BK1574","BK1161","AIPO","HK0000320264.USD","MRNX","MRNY","03069","BK1191","IBBQ","VTHR","HK0000306701.USD","HK0000165453.HKD","BBP","HK0000306685.HKD","ARTY","QTOC","02696","01477","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132454908","title":"特朗普：8月就业数据超预期，要求美联储降息","url":"https://stock-news.laohu8.com/highlight/detail?id=1132454908","media":"特朗普社媒动态","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132454908?lang=zh_cn&edition=fundamental","pubTime":"2026-09-04 21:41","pubTimestamp":1788529306,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRCY","VAW","PEVC","ANEW","FXL","IJK","DFUV",".DJI","RJZ","BBP","TSLP","CGDV",".SPX","FXR","AVSD",".IXIC","UCC","CLIX","KOMP","CAOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664337721","title":"康宁杰瑞生物制药回购56,000股 耗资492,430港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664337721","media":"财闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664337721?lang=zh_cn&edition=fundamental","pubTime":"2026-09-04 20:53","pubTimestamp":1788526380,"startTime":"0","endTime":"0","summary":"9月4日，康宁杰瑞生物制药于2026年9月4日在香港联交所回购56,000股普通股，每股回购价格最高HKD8.8、最低HKD8.75，付出价格总额HKD492,430。回购股份拟持作库存股份，拟注销数目为0。回购后，已发行股份数目由968,056,697股减至968,000,697股，库存股份数目由6,325,000股增至6,381,000股，已发行股份总数维持974,381,697股。此次回购依据2026年6月12日获通过的回购授权进行，该授权可回购股份总数为96,850,669股。回购后暂止期截至2026年10月4日。呈交者为执行董事徐霆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-04/doc-iniqsrak4001786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EWH","03069","BBP","MRNY","MRNX","IBBQ","CNAV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股异动丨诺华制药涨超7%，多发性硬化症口服药后期临床试验结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664521258?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBH","RXL","MEDX","XPH","IE0002141913.USD","LU2322448957.HKD","NVS","LU0211331839.USD","SBIO","HELX","MEDI","IE00BJJMRZ35.SGD","PBPH","IEIH","FTXH","IBB","BIOY","IE0009355771.USD","BBP","MRNY","BIB","PJP","IEHS","TMED","BME","PPH","CANC","MRNX","IE00BFTCPJ56.SGD","LU2473716301.USD","LFSC","SYNB","FBT","AZNH","BK4588","PBE","IDNA","BK4585","GNOM","LU0070302665.USD","LU2272731600.USD","PSCH","RSPH","WDNA","XBIX","IE00B4R5TH58.HKD","IBRN","IYH","IE00BJT1NW94.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663282078","title":"药闻 | 英硅智能上市后首份半年报扭亏 创新药研发加速拥抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663282078?lang=zh_cn&edition=fundamental","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电（记者杜康）作为AI制药领域代表性企业之一，英硅智能（03696.HK）日前发布2026年度中期业绩报告。上半年，公司实现总营收1.063亿美元，同比增长287.2%；净利润3554万美元，经调整净利润5123万美元，经营活动现金流转正。这是英硅智能上市后发布的首份半年报，公司也由此前的亏损转为盈利。从收入结构看，药物研发与管线开发仍是主要来源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SBIO","BK4588","IPOS","VTHR","AIPO","BIOY","GDOC","WRND","CHAT","GSKH","BK4585","LFSC","APXH","BBP","PBE","QTOC","IBB","ARTY","AGIX","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663238000","title":"武汉友芝友生物制药股份有限公司在香港暂停交易。","url":"https://stock-news.laohu8.com/highlight/detail?id=2663238000","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663238000?lang=zh_cn&edition=fundamental","pubTime":"2026-08-31 08:36","pubTimestamp":1788136595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBP","MRNX","IBBQ","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663302804","title":"新股消息 | 贝达药业(300558.SZ)再度递表港交所 “四驾马车”协同打造全产业链生物制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2663302804","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663302804?lang=zh_cn&edition=fundamental","pubTime":"2026-08-31 08:14","pubTimestamp":1788135285,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所8月28日披露，贝达药业股份有限公司向港交所主板提交上市申请，中信证券为其独家保荐人。毛利率于2023年度、2024年度、2025年度及2026年截至6月30日止六个月，公司对应毛利率分别为82.7%、80.5%、78.3%、75.1%。全球及中国的肺癌发病率和死亡率均呈上升趋势。全球肺癌新发病例数从2020 年的230万增至2025年的270万，预计到2035年将增至350万。目前，FDA已批准6种ALK TKI上市，EMA已批准5种ALK TKI上市，国家药监局已批准10种ALK TKI上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRNY","HEXmain","03069","BK0239","BBP","MRNX","IPOS","IBBQ","BK0060","300558"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044177","title":"联环药业上半年扭亏为盈 集采续采与创新药研发协同推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044177","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044177?lang=zh_cn&edition=fundamental","pubTime":"2026-08-30 21:12","pubTimestamp":1788095520,"startTime":"0","endTime":"0","summary":"业绩实现扭亏为盈经营基本面持续改善今年上半年，联环药业经营业绩实现明显改善。对此，联环药业正持续推进相关工作。值得注意的是，联环药业已经开始围绕创新药商业化进行营销体系布局。除LH-1801外，联环药业产品注册申报也取得阶段性进展。从核心产品稳定销售，到集采品种持续放量，再到创新药研发向上市申报环节推进，联环药业正在逐步形成多层次的业务增长支撑。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBB","BIOY","BK4588","BBP","LFSC","WRND","GDOC","BK4585","600513","XLVI","PBE","APXH","BK0239","SBIO","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058121","title":"海正药业与星际开发达成战略合作 布局太空生物制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058121","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058121?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 10:52","pubTimestamp":1787885542,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNY","MRNX","BBP","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752987","title":"博济医药2026年半年报：创新药研发需求复苏，在手订单充足，经营现金流明显下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752987","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752987?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 14:57","pubTimestamp":1787813849,"startTime":"0","endTime":"0","summary":"然而，需警惕新药研发政策变化、项目执行延期及市场竞争加剧带来的风险，同时关注经营现金流与净利润背离的情况。后续需重点关注公司在手订单转化进度、临床前及临床研究服务的毛利率变化趋势，以及经营现金流的改善情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787797151251328663","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IBB","BIOY","BK4588","BBP","LFSC","SPHQ","GDOC","WRND","BK4585","300404","159399","XLVI","PBE","APXH","BK0216","SBIO","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661672552","title":"阿巴斯生物制药宣布拟通过改良式“荷兰拍卖”要约收购，回购最高价值2.3亿美元的公司普通股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661672552","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661672552?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 19:30","pubTimestamp":1787311853,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","BBP","MRNY","EVNT","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"骏利亨德森投资：专利到期倒逼药企扩张 生物科技并购、IPO市场同步复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称，尽管利率较市场年初的预期为高，但生物科技行业交易活动的增长动力持续不减。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IBBJ","IBB","IJT","PBE","BIS","BK4582","IYG","IAI","GTPE","JDOC","BBP","MRNY","BK4585","IWO","BBC","MRNX","FBT","QSML","BIB","BK4588","SPCK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660415061","title":"杭萧钢构等投资成立生物制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2660415061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660415061?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 09:44","pubTimestamp":1787103899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBP","MRNY","MRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659504119","title":"中国银河证券：实验动物为创新药研发刚需 小鼠+猴双主线高景气","url":"https://stock-news.laohu8.com/highlight/detail?id=2659504119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659504119?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 15:07","pubTimestamp":1786691225,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国银河证券发布研报称，实验动物为创新药研发刚需，行业壁垒深厚，两大细分赛道具备中长期成长逻辑：人源化小鼠赛道成长确定性更强、周期波动平缓;实验猴赛道供给约束强，短期价格上行带来显著业绩弹性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["WRND","BK4588","XLVI","IBB","161027","BK1564","SBIO","GSKH","LFSC","GDOC","BIOY","PBE","BBP","601881","06881","BK4585","BK0276","APXH","BK0188","BK1147"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":63,"code":"91000000","status":"200"}]}}